Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Macrophage nitric oxide (NO) generation refers to the process by which macrophages produce NO, a reactive gaseous molecule with key roles in host defense, immunoregulation, and cellular metabolism. The primary enzyme responsible is inducible nitric oxide synthase (iNOS), which converts L-arginine and molecular oxygen into NO and L-citrulline. NO production is induced by pro-inflammatory cytokines and microbial products. It enables macrophages to exert cytostatic or cytotoxic effects against pathogens and tumor cells, as well as modulates cellular metabolism. Dysregulated NO production can contribute to harmful inflammation and tissue damage. Some pathogens have evolved mechanisms that inhibit iNOS expression as an immune evasion strategy.
Modulation of iNOS expression and activity; regulation of arginine metabolism; scavenging of NO.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macrophage Nitric Oxide Generation (Macrophage NO Generation).